Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells
- PMID: 17143331
- PMCID: PMC1679707
- DOI: 10.1172/JCI28510
Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells
Abstract
Obesity and weight gain are characterized by increased adipose tissue mass due to an increase in the size of individual adipocytes and the generation of new adipocytes. New adipocytes are believed to arise from resident adipose tissue preadipocytes and mesenchymal progenitor cells. However, it is possible that progenitor cells from other tissues, in particular BM, could also contribute to development of new adipocytes in adipose tissue. We tested this hypothesis by transplanting whole BM cells from GFP-expressing transgenic mice into wild-type C57BL/6 mice and subjecting them to a high-fat diet or treatment with the thiazolidinedione (TZD) rosiglitazone (ROSI) for several weeks. Histological examination of adipose tissue or FACS of adipocytes revealed the presence of GFP(+) multilocular (ML) adipocytes, whose number was significantly increased by ROSI treatment or high-fat feeding. These ML adipocytes expressed adiponectin, perilipin, fatty acid-binding protein (FABP), leptin, C/EBPalpha, and PPARgamma but not uncoupling protein-1 (UCP-1), the CD45 hematopoietic lineage marker, or the CDllb monocyte marker. They also exhibited increased mitochondrial content. Appearance of GFP(+) ML adipocytes was contemporaneous with an increase in circulating levels of mesenchymal and hematopoietic progenitor cells in ROSI-treated animals. We conclude that TZDs and high-fat feeding promote the trafficking of BM-derived circulating progenitor cells to adipose tissue and their differentiation into ML adipocytes.
Figures







Comment in
-
Search for the preadipocyte progenitor cell.J Clin Invest. 2006 Dec;116(12):3103-6. doi: 10.1172/JCI30666. J Clin Invest. 2006. PMID: 17143324 Free PMC article.
Similar articles
-
Search for the preadipocyte progenitor cell.J Clin Invest. 2006 Dec;116(12):3103-6. doi: 10.1172/JCI30666. J Clin Invest. 2006. PMID: 17143324 Free PMC article.
-
Hematopoietic stem cell origin of adipocytes.Exp Hematol. 2009 Sep;37(9):1108-20, 1120.e1-4. doi: 10.1016/j.exphem.2009.06.008. Epub 2009 Jul 2. Exp Hematol. 2009. PMID: 19576951 Free PMC article.
-
Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.Diabetes. 1998 Jan;47(1):138-41. doi: 10.2337/diab.47.1.138. Diabetes. 1998. PMID: 9421389
-
Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats.Obesity (Silver Spring). 2007 Nov;15(11):2653-63. doi: 10.1038/oby.2007.317. Obesity (Silver Spring). 2007. PMID: 18070756
-
Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.Obesity (Silver Spring). 2008 Sep;16(9):1983-91. doi: 10.1038/oby.2008.326. Obesity (Silver Spring). 2008. PMID: 19186324
Cited by
-
Adipose Tissue Dysfunction Determines Lipotoxicity and Triggers the Metabolic Syndrome: Current Challenges and Clinical Perspectives.Adv Exp Med Biol. 2024;1460:231-272. doi: 10.1007/978-3-031-63657-8_8. Adv Exp Med Biol. 2024. PMID: 39287854 Review.
-
PPARs and Adipose Cell Plasticity.PPAR Res. 2007;2007:68202. doi: 10.1155/2007/68202. PPAR Res. 2007. PMID: 17710234 Free PMC article.
-
Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow.BMC Dev Biol. 2010 May 7;10:47. doi: 10.1186/1471-213X-10-47. BMC Dev Biol. 2010. PMID: 20459638 Free PMC article.
-
Adipose-derived stem cells for regenerative medicine.Circ Res. 2007 May 11;100(9):1249-60. doi: 10.1161/01.RES.0000265074.83288.09. Circ Res. 2007. PMID: 17495232 Free PMC article. Review.
-
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.Nat Rev Drug Discov. 2010 Feb;9(2):107-15. doi: 10.1038/nrd3055. Nat Rev Drug Discov. 2010. PMID: 20118961 Review.
References
-
- Steppan C.M., Lazar M.A. Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 2002;13:18–23. - PubMed
-
- Poissonnet C.M., Burdi A.R., Garn S.M. The chronology of adipose tissue appearance and distribution in human fetus. Early Hum. Dev. 1984;10:1–11. - PubMed
-
- Poissonnet C.M., Lavelle M., Burdi A.R. Growth and development of adipose tissue. J. Pediatr. 1988;113:1–9. - PubMed
-
- Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 1992;12:207–233. - PubMed
-
- Garaulet M., Hernandez-Morante J.J., Lujan J., Tebar F.J., Zamora S. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int. J. Obes. (Lond.). . 2006;30:899–905. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous